Advertisement

The Complex Interplay of Cortex, Cerebellum, and Age in a Cohort of Pediatric Patients With Tuberous Sclerosis Complex

      Abstract

      Background

      The neurodevelopmental impairment in tuberous sclerosis complex (TSC) has a multifactorial origin. Various factors have been proposed as predictors of neurological outcome such as tuber load, seizure onset, and TSC2 mutation. Cerebellar lesions have been associated with worse neuroradiological phenotype, but their contribution is not well understood.

      Methods

      A partly retrospective and partly prospective pediatric cohort study was conducted at three hospitals in Greece between 2015 and 2020. Patients aged ≤ 18 years with a confirmed TSC daignosis were included and underwent brain imaging, a semistructured interview (authorized Greek version of the tuberous sclerosis-associated neuropsychiatric disorders, or TAND, checklist), and intellectual ability assessment.

      Results

      The study populations consisted of 45 patients with TSC (22 females, 23 males; mean age 9.53 years). Twenty patients (44.4%) had cerebellar lesions. Cerebellar involvement was the most powerful predictor of tuber load (P = 0.03). Cerebellar lesions were associated with giant cell astrocytomas (SEGAs) (P = 0.01) and severe neurological outcome (P = 0.01). Even though in the univariate analysis early seizure onset, tuber load, and cerebellar involvement were associated with intellectual impairment and neurological severity, none of them was an independent predictor of cognitive outcome and neurological severity.

      Conclusions

      Cerebellar lesions are common among individuals with TSC. Cerebellar involvement correlates with supratentorial derangement and the development of SEGAs, which is suggestive of a more severe clinical and neuroradiological phenotype. Cerebellar involvement and early seizure onset were not independent predictors of either neurological severity or intellectual disability or neurobehavioral outcome; their role in TSC clinical phenotype should be further investigated.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Pediatric Neurology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Roach E.S.
        Applying the lessons of tuberous sclerosis: the 2015 Hower Award Lecture.
        Pediatr Neurol. 2016; 63: 6-22
        • Curatolo P.
        • Moavero R.
        • de Vries P.J.
        Neurological and neuropsychiatric aspects of tuberous.
        Lancet Neurol. 2015; 14: 733-745
        • Joinson C.
        • O'Callaghan F.J.
        • Osborne J.P.
        • Martyn C.
        • Harris T.
        • Bolton P.F.
        Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex.
        Psychol Med. 2003; 33: 335-344
        • Goodman M.
        • Lamm S.H.
        • Engel A.
        • Shepherd C.W.
        • Houser O.W.
        • Gomez M.R.
        Cortical tuber count: a biomarker indicating neurologic severity of tuberous sclerosis complex.
        J Child Neurol. 1997; 12: 85-90
        • Roach E.S.
        • Williams D.P.
        • Laster D.W.
        Magnetic resonance imaging in tuberous sclerosis.
        Arch Neurol. 1987; 44: 301-303
        • Jansen F.E.
        • Vincken K.L.
        • Algra A.
        • et al.
        Cognitive impairment in tuberous sclerosis complex is a multifactorial condition.
        Neurology. 2008; 70: 916-923
        • Bolton P.F.
        • Clifford M.
        • Tye C.
        • et al.
        Intellectual abilities in tuberous sclerosis complex: risk factors and correlates from the Tuberous Sclerosis 2000 Study.
        Psychol Med. 2015; 45: 2321-2331
        • Toldo I.
        • Bugin S.
        • Perissinotto E.
        • et al.
        Cerebellar lesions as potential predictors of neurobehavioural phenotype in tuberous sclerosis complex.
        Dev Med Child Neurol. 2019; 61: 1221-1228
        • Tye C.
        • Mcewen F.S.
        • Liang H.
        • et al.
        Long-term cognitive outcomes in tuberous sclerosis complex.
        Dev Med Child Neurol. 2020; 62: 322-329
        • Northrup H.
        • Krueger D.A.
        • Roberds S.
        • et al.
        Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference.
        Pediatr Neurol. 2013; 49: 243-254
        • Sidira C.
        • Vargiami E.
        • Laina I.
        • et al.
        Neuropsychiatric disorders associated with tuberous sclerosis complex- TAND (TSC-associated neuropsychiatric-disorders) and the TAND checklist.
        Pediatr Neurol. 2020; 83: 90-105
        • Georgas J.
        • Paraskevopoulos I.N.
        • Besevegis E.
        • Giannitsas N.D.
        The Hellenic WISC-III.
        Psychometric Laboratory, University of Athens, Athens1997
        • Ivens J.
        A common metric for the Griffiths Scales.
        Arch Dis Child. 2002; 87: 109-110
        • Kwan P.
        • Arzimanoglou A.
        • Berg A.T.
        • et al.
        Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies.
        Epilepsia. 2009; 51: 1069-1077
        • Wong A.M.
        • Wang H.-S.
        • Schwartz E.S.
        • et al.
        Cerebral diffusion tensor MR tractography in tuberous sclerosis complex: correlation with neurologic severity and tract-based spatial statistical analysis.
        AJNR Am J Neuroradiol. 2013; 34: 1829-1835
        • de Vries P.J.
        • Whittemore V.H.
        • Leclezio L.
        • et al.
        Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND checklist.
        Pediatr Neurol. 2015; 52: 25-35
        • Ridler K.
        • Suckling J.
        • Higgins N.
        • Bolton P.
        • Bullmore E.
        Standardized whole brain mapping of tubers and subependymal nodules in tuberous sclerosis complex.
        J Child Neurol. 2004; 19: 658-665
        • Weisenfeld N.I.
        • Peters J.M.
        • Tsai P.T.
        • et al.
        A magnetic resonance imaging study of cerebellar volume in tuberous sclerosis complex.
        Pediatr Neurol. 2013; 48: 105-110
        • Martí-Bonmatí L.
        • Menor F.
        • Dosdá R.
        Tuberous sclerosis: differences between cerebral and cerebellar cortical tubers in a pediatric population.
        AJNR Am J Neuroradiol. 2000; 21: 557-560
        • Daghistani R.
        • Rutka J.
        • Widjaja E.
        MRI characteristics of cerebellar tubers and their longitudinal changes in children with tuberous sclerosis complex.
        Childs Nerv Syst. 2015; 31: 109-113
        • Vaughn J.
        • Hagiwara M.
        • Katz J.
        • et al.
        MRI characterization and longitudinal study of focal cerebellar lesions in a young tuberous sclerosis cohort.
        AJNR Am J Neuroradiol. 2013; 34: 655-659
        • Jurkiewicz E.
        • Jóźwiak S.
        • Bekiesińska-Figatowska M.
        • Pakieła-Domańska D.
        • Pakuła-Kościesza I.
        • Walecki J.
        Cerebellar lesions in children with tuberous sclerosis complex.
        Neuroradiol J. 2006; 19: 577-582
        • Boronat S.
        • Thiele E.A.
        • Caruso P.
        Cerebellar lesions are associated with TSC2 mutations in tuberous sclerosis complex: a retrospective record review study.
        Dev Med Child Neurol. 2017; 59: 1071-1076
        • Manara R.
        • Bugin S.
        • Pelizza M.F.
        • et al.
        Genetic and imaging features of cerebellar abnormalities in tuberous sclerosis complex: more insights into their pathogenesis.
        Dev Med Child Neurol. 2018; 60: 724-725
        • van Eeghen A.M.
        • Terán L.O.
        • Johnson J.
        • Pulsifer M.B.
        • Thiele E.A.
        • Caruso P.
        The neuroanatomical phenotype of tuberous sclerosis complex: focus on radial migration lines.
        Neuroradiology. 2013; 55: 1007-1014
        • Jay V.
        • Edwards V.
        • Musharbash A.
        • Rutka J.T.
        Cerebellar pathology in tuberous sclerosis.
        Ultrastruct Pathol. 1998; 22: 331-339
        • Pinto Gama H.P.
        • da Rocha A.J.
        • Braga F.T.
        • et al.
        Comparative analysis of MR sequences to detect structural brain lesions in tuberous sclerosis.
        Pediatr Radiol. 2006; 36: 119-125
        • Sener R.N.
        Cerebellar involvement in tuberous sclerosis.
        Comput Med Imaging Graph. 1998; 22: 63-65
        • Eluvathingal T.J.
        • Behen M.E.
        • Chugani H.T.
        • et al.
        Cerebellar lesions in tuberous sclerosis complex.
        J Child Neurol. 2006; 21: 846-851
        • Yapıcı Z.
        • Dörtcan N.
        • Baykan B.B.
        • et al.
        Neurological aspects of tuberous sclerosis in relation to MRI/MR spectroscopy findings in children with epilepsy.
        Neurol Res. 2007; 29: 449-454
        • Srivastava S.
        • Prohl A.K.
        • Scherrer B.
        • et al.
        Cerebellar volume as an imaging marker of development in infants with tuberous sclerosis complex.
        Neurology. 2018; 90: 1493-1500
        • Salman M.S.
        • Tsai P.
        The role of the pediatric cerebellum in motor functions, cognition, and behavior.
        Neuroimaging Clin N Am. 2016; 26: 317-329
        • Sundberg M.
        • Sahin M.
        Cerebellar development and autism spectrum disorder in tuberous sclerosis complex.
        J Child Neurol. 2015; 30: 1954-1962
        • Jansen A.C.
        • Belousova E.
        • Benedik M.P.
        • et al.
        Clinical characteristics of subependymal giant cell astrocytoma in tuberous sclerosis complex.
        Front Neurol. 2019; 10: 705
        • Jansen F.E.
        • Braams O.
        • Vincken K.L.
        • et al.
        Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations.
        Neurology. 2008; 70: 908-915
        • Overwater I.E.
        • Verhaar B.J.H.
        • Lingsma H.F.
        • et al.
        Interdependence of clinical factors predicting cognition in children with tuberous sclerosis complex.
        J Neurol. 2017; 264: 161-167
        • Kaczorowska M.
        • Jurkiewicz E.
        • Domańska-Pakieła D.
        • et al.
        Cerebral tuber count and its impact on mental outcome of patients with tuberous sclerosis complex.
        Epilepsia. 2011; 52: 22-27
        • de Vries P.J.
        • Wilde L.
        • de Vries M.C.
        • Moavero R.
        • Pearson D.A.
        • Curatolo P.
        A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND).
        Am J Med Genet C Semin Med Genet. 2018; 178: 309-320
        • Dabora S.L.
        • Jozwiak S.
        • Franz D.N.
        • et al.
        Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.
        Am J Hum Genet. 2001; 68: 64-80
        • Kopp C.M.C.
        • Muzykewicz D.A.
        • Staley B.A.
        • Thiele E.A.
        • Pulsifer M.B.
        Behavior problems in children with tuberous sclerosis complex and parental stress.
        Epilepsy Behav. 2008; 13: 505-510
        • Prather P.
        • de Vries P.J.
        Behavioral and cognitive aspects of tuberous sclerosis complex.
        J Child Neurol. 2004; 19: 666-674